Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | protease, serine, 1 (trypsin 1) | Starlite/ChEMBL | References |
Homo sapiens | coagulation factor X | Starlite/ChEMBL | References |
Homo sapiens | coagulation factor II (thrombin) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Trypsin family protein | protease, serine, 1 (trypsin 1) | 247 aa | 287 aa | 21.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0124 | 1 | 1 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0124 | 1 | 1 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0124 | 1 | 1 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Giardia lamblia | Beta tubulin | 0.0028 | 0.047 | 0.5 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0124 | 1 | 1 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0124 | 1 | 1 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0124 | 1 | 1 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0124 | 1 | 1 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0124 | 1 | 1 |
Echinococcus multilocularis | tubulin, beta 4A class IVa | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Echinococcus multilocularis | beta tubulin | 0.0028 | 0.047 | 0.047 |
Giardia lamblia | Beta tubulin | 0.0028 | 0.047 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Giardia lamblia | Beta tubulin | 0.0028 | 0.047 | 0.5 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0124 | 1 | 1 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0124 | 1 | 1 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0124 | 1 | 1 |
Echinococcus granulosus | beta tubulin | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0124 | 1 | 1 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Onchocerca volvulus | 0.012 | 0.9598 | 1 | |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Echinococcus multilocularis | beta tubulin | 0.0028 | 0.047 | 0.047 |
Echinococcus granulosus | tubulin beta 4A class IVa | 0.0028 | 0.047 | 0.047 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.012 | 0.9598 | 0.9578 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0124 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.012 | 0.9598 | 0.9578 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.9598 | 0.9578 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Echinococcus granulosus | tubulin subunit beta | 0.0028 | 0.047 | 0.047 |
Brugia malayi | Trypsin family protein | 0.012 | 0.9598 | 0.9578 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0124 | 1 | 1 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0124 | 1 | 1 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0124 | 1 | 1 |
Echinococcus granulosus | tubulin beta 1 chain | 0.0028 | 0.047 | 0.047 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0028 | 0.047 | 0.047 |
Echinococcus multilocularis | tubulin subunit beta | 0.0028 | 0.047 | 0.047 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.9598 | 0.9578 |
Echinococcus granulosus | beta tubulin | 0.0028 | 0.047 | 0.047 |
Leishmania major | beta tubulin | 0.0028 | 0.047 | 0.047 |
Echinococcus multilocularis | tubulin beta 1 chain | 0.0028 | 0.047 | 0.047 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.0187 uM | In vitro inhibition of human coagulation factor Xa. | ChEMBL. | 11677132 |
IC50 (binding) | = 0.0187 uM | In vitro inhibition of human coagulation factor Xa. | ChEMBL. | 11677132 |
IC50 (binding) | = 4.39 uM | In vitro inhibition of human trypsin. | ChEMBL. | 11677132 |
IC50 (binding) | = 4.39 uM | In vitro inhibition of human trypsin. | ChEMBL. | 11677132 |
IC50 (binding) | > 10 uM | In vitro inhibition of human thrombin. | ChEMBL. | 11677132 |
IC50 (binding) | > 10 uM | In vitro inhibition of human thrombin. | ChEMBL. | 11677132 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.